-
Anesta AG et al v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:08-cv-00889
- D. Del.
- Judge: Sue L. Robinson
- Filed: 11/25/2008
- Closed: 09/24/2014
- Latest Docket Entry: 12/18/2014
- PACER
- Docket updated daily
5
Plaintiffs
7
Defendants
1
Accused
Product
2
Patents-in-Suit
2,130
Days in
Litigation
-
Anesta AG et al v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:08-cv-00889
- D. Del.
- Judge: Sue L. Robinson
- Filed: 11/25/2008
- Closed: 09/24/2014
- Latest Docket Entry: 12/18/2014
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Anchen Pharmaceuticals
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule | US 7,387,793 B2 | All Asserted Claims |
No infringement
Entry 42
|
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule | US 7,544,372 B2 | All Asserted Claims |
No infringement
Entry 42
|
Barr Laboratories Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule | US 7,387,793 B2 | All Asserted Claims |
Infringement
Entry 42
|
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule | US 7,544,372 B2 | All Asserted Claims |
Infringement
Entry 42
|
Mylan Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 mg cyclobenzaprine hydrochloride extended-release capsules30mg cyclobenzaprine hydrochloride extended-release capsules, | US 7,387,793 B2 | All Asserted Claims |
No infringement
Entry 416
|
| 15 mg cyclobenzaprine hydrochloride extended-release capsules30mg cyclobenzaprine hydrochloride extended-release capsules, | US 7,544,372 B2 | All Asserted Claims |
No infringement
Entry 416
|
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule15 mg cyclobenzaprine hydrochloride extended-release capsules30mg cyclobenzaprine hydrochloride extended-release capsules, | US 7,387,793 B2 | All Asserted Claims |
Infringement
Entry 42Entry 416 |
| 15 mg, 30 mg cyclobenzaprine hydrochloride extended-release capsule15 mg cyclobenzaprine hydrochloride extended-release capsules30mg cyclobenzaprine hydrochloride extended-release capsules, | US 7,544,372 B2 | All Asserted Claims |
Infringement
Entry 42Entry 416 |
